Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
1,479 INR | +0.05% | +2.58% | +18.71% |
May. 27 | Indian drugmakers to see FY25 revenue boost in key US market, says India Ratings and Research | RE |
May. 23 | Nomura Adjusts Cipla’s Price Target to INR1,535 From INR1,486, Keeps at Neutral | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+18.71% | 14.36B | |
+16.31% | 42.32B | |
+16.00% | 21.29B | |
+19.33% | 15.29B | |
+52.78% | 12.81B | |
-0.05% | 6.79B | |
-12.50% | 6.58B | |
-8.87% | 5.73B | |
+14.28% | 5.51B | |
+7.31% | 4.91B |
- Stock Market
- Equities
- CIPLA Stock
- News Cipla Limited
- Cipla's Consolidated Net Profit Climbs in Fiscal Q4; Shares Up 6%